Plum collaborates with RazorpayX to provide health insurance to SMEs and start-ups

▴ Plum collaborates with RazorpayX to provide health insurance to SMEs and start-ups
Less than two-year-old startup, Plum has gained significant success in India's untapped insurance sector. Will their collaboration with RazorpayX boost their market position further?

Covid-19 has boosted the insurance sector globally. In 2020, the global health insurance sector was valued at a whopping $1.98 trillion and it is estimated to reach $4.15 trillion by 2028. Closer home the health insurance market remains an untapped domain of potential. It has been growing annually by 25% and is estimated to be around $3.5 billion. Yet it has only a mere 9 crores Indians covered with insurance. More than 100 million remain uncovered, making this industry the future goldmine.

 The potential of this sector didn’t go missing by Plum’s co-founders Saurabh Arora and Abhishek Poddar. They noticed that digital distribution of insurance markets accounts for only 1%. They launched Plum in November 2019. This startup aimed to make buying health insurance more affordable and accessible for organizations. Any company can get insurance on Plum with three simple clicks. For this, the startup maintains close ties with ICICI Lombard, New India Assurance, Care Health, and Star Health. 

Starting with $1 million in its first-ever fund, Plum gradually made more space for itself. Finally, after five rounds it gained an aggregate of $20.6 million in less than 2 years since inception. In a short time, their clientele grew to include Unacademy, Groww, CleverTap, Simpl and 600 more organizations. 

Its angel investors include notable names of the Indian startup sector, including Roman Saini, Gaurav Munjal and Hemesh Singh (founders of Unacademy); Kunal Shah (founder of Cred), Douglas Feirsten (founder of Hired); Lalit Keshre, Harsh Jain, and Ishan Bansal (founders of Groww) and Ramakant Sharma and Anuj Srivastava (founders of Livspace).

Its first funds came from Incubate Funds as seed funds followed by two rounds of pre-seed funds. This May, Tiger Global, the most prolific investor who has backed over 20 Indian unicorns, gave $15.6 million to accelerate Plum’s growth in its Series A funding. Other investors in it were Sequoia Capital India’s Surge, Tanglin Venture Partners, and Incubate Fund. 

Plum enjoys a rather comfortable position in the insurance sector. Where most insurance firms concentrate their efforts on individual consumers, Plum focuses on business firms. More importantly on small firms and startups. 

To strengthen its position it has collaborated with RazorpayX and launched RazorpayX Health Insurance that provides health insurance to even firms with just 2 employees. The first-of-its-kind insurance will collaborate with small businesses giving them health insurance packages of three kinds - Starter Plan covering basics; Essential Plan covering pre-existing disease and Premium Plan covering maternity benefits. Such collaboration may help Plum to fulfill its vision of achieving Indian health insurance penetration to its fullest, 100%. 

A 2020 Deloitte India survey claims that 30% of employees in tech startups change their jobs every year. Out of this 47% do so for better working conditions. With an ever-increasing flux of new employees, startups face severe instability. Will covering employees' health insurance be a strong enough perk for employees to stay with the organization? How important will Plum’s collaboration with RazorpayX help startups in retaining good talent?

Tags : #Plum #RazorpayX #SaurabhArora #AbhishekPoddar #InsuranceSector #funding #insurance #Deloitte #smitakumar #medicircle

Related Stories

18 Jun

FDA approves nasal antihistamine for nonprescription use

Seasonal allergies affect millions causing nasal congestion, runny nose and sneezing. Approval of Asteopro (Azelastine Hydrochloride nasal spray 0.15%) can help many patients with allergies.

View
23 Dec

Glenmark collaborates with Menarini for commercializing Ryaltris nasal spray across Europe

The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain

View
18 Dec

Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals

Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in a gold standard ferret study, has been published in two leading international peer-reviewed journals.

View
07 Oct

Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the U.S. FDA for Dimethyl Fumarate DR Capsules, the generic version of Tecfidera

View
18 Aug

Glenmark appoints Dipankar Bhattacharjee to its Board of Directors

Glenmark Pharmaceuticals announced the appointment of Mr Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization

View
30 Jul

Food Allergies: All that you have to know

Skin prick testing can in some cases produce bogus negative or bogus positive outcomes.

View
21 May

Cipla receives final approval for Migranal

Cipla receives final approval for generic version of Migranal (Dihydroergotamine Mesylate Nasal Spray) with a Competitive Generic Therapy Designation

View
12 May

Hikma Announces the Launch of Propofol Injectable Emulsion, USP

Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP. Sedative for patients on ventilators currently in short supply in the US

View
28 Feb

Glenmark Pharma Signs an Exclusive Licensing Agreement with Hikma Pharmaceuticals

Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltrisâ„¢ by the US FDA, while Hikma will be responsible for the commercialization of Ryaltrisâ„¢ in the US.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025